Delayed administration of TAT.ARC protein attenuates focal ischemic brain injury: Mice were subjected to 60 min MCAo and 5 µg TAT.ARC or control protein was injected 3 h after the onset of ischemia and indirect lesion volume was assessed after 3 days.
Junfeng An, Christoph Harms(Charité - Universitätsmedizin Berlin), Janet Lips(Charité - Universitätsmedizin Berlin), Ulrich Dirnagl(German Center for Neurodegenerative Diseases), Gisela Lättig-Tünnemann(Stroke Association), Susanne Mueller(Charité - Universitätsmedizin Berlin), Anna Lena Dätwyler(Stroke Association), Marco Foddis(Charité - Universitätsmedizin Berlin), Golo Kronenberg(University of Zurich), René Bernard(Charité - Universitätsmedizin Berlin), Larissa Mosch(Stroke Association), Karen Gertz(Humboldt-Universität zu Berlin), Ulrike Grittner(Charité - Universitätsmedizin Berlin), Ulrike Harms(Stroke Association), Mustafa Balkaya(Institute of Experimental Endocrinology of the Slovak Academy of Sciences), Tracy D. Farr(University of Nottingham), Stefan Donath(Max Delbrück Center), Matthias Endres(German Center for Neurodegenerative Diseases)
Cited by 1
Related Papers
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2.8k
Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2018|2k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948